JPH0310692A - Antibiotic substance om-5714 and production thereof - Google Patents
Antibiotic substance om-5714 and production thereofInfo
- Publication number
- JPH0310692A JPH0310692A JP14509989A JP14509989A JPH0310692A JP H0310692 A JPH0310692 A JP H0310692A JP 14509989 A JP14509989 A JP 14509989A JP 14509989 A JP14509989 A JP 14509989A JP H0310692 A JPH0310692 A JP H0310692A
- Authority
- JP
- Japan
- Prior art keywords
- antibiotic
- chloroform
- culture
- methanol
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000126 substance Substances 0.000 title claims abstract description 18
- 230000003115 biocidal effect Effects 0.000 title claims description 34
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 36
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 24
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000187747 Streptomyces Species 0.000 claims abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 4
- 230000007935 neutral effect Effects 0.000 claims abstract description 4
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000002844 melting Methods 0.000 claims abstract description 3
- 230000008018 melting Effects 0.000 claims abstract description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000012445 acidic reagent Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 13
- 238000000862 absorption spectrum Methods 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 claims description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims 1
- 230000002363 herbicidal effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 239000003905 agrochemical Substances 0.000 abstract description 2
- 244000000004 fungal plant pathogen Species 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- JYVHOGDBFNJNMR-UHFFFAOYSA-N hexane;hydrate Chemical compound O.CCCCCC JYVHOGDBFNJNMR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 239000000741 silica gel Substances 0.000 description 8
- 229910002027 silica gel Inorganic materials 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 241000233614 Phytophthora Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 244000088415 Raphanus sativus Species 0.000 description 2
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 2
- 241000187180 Streptomyces sp. Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- -1 methanol and ethanol Chemical compound 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- 101100019528 Homo sapiens KRT71 gene Proteins 0.000 description 1
- 101100126680 Homo sapiens KRT78 gene Proteins 0.000 description 1
- 102100025370 Keratin, type II cytoskeletal 71 Human genes 0.000 description 1
- 102100023969 Keratin, type II cytoskeletal 78 Human genes 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000235526 Mucor racemosus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229930182764 Polyoxin Natural products 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001362984 Streptomyces sp. E Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NKNPHSJWQZXWIX-UHFFFAOYSA-N Tetranactin Natural products CC1C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC(O2)CCC2C(C)C(=O)OC(CC)CC2CCC1O2 NKNPHSJWQZXWIX-UHFFFAOYSA-N 0.000 description 1
- NKNPHSJWQZXWIX-DCVDGXQQSA-N Tetranactin Chemical compound C[C@H]([C@H]1CC[C@H](O1)C[C@@H](OC(=O)[C@@H](C)[C@@H]1CC[C@@H](O1)C[C@@H](CC)OC(=O)[C@H](C)[C@H]1CC[C@H](O1)C[C@H](CC)OC(=O)[C@H]1C)CC)C(=O)O[C@H](CC)C[C@H]2CC[C@@H]1O2 NKNPHSJWQZXWIX-DCVDGXQQSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 241001660687 Xantho Species 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- SCJNCDSAIRBRIA-DOFZRALJSA-N arachidonyl-2'-chloroethylamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCCl SCJNCDSAIRBRIA-DOFZRALJSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【発明の詳細な説明】
LL上り五皿分1
本発明は抗生物質に関し、特に新規抗生物質OM−57
14およびその製法に関する。[Detailed Description of the Invention] LL 5 servings 1 The present invention relates to antibiotics, and particularly to the novel antibiotic OM-57.
14 and its manufacturing method.
l股り且l
抗真菌性抗生物質として、例えば、アムホテリシンB1
グリセオフルビン、ビロールニドリン等の医薬や、プラ
スチシジンS、ポリオキシン、バリダマイシン、テトラ
ナクチン、ビアラフオス等の農薬が知られている。しか
し公知の抗真菌性抗生物質は、例えば、薬効、毒性、抗
菌性等の点においてなお改良の余地がある1本発明は、
発明者が土壌から分離した放線菌が、特に植物病原菌に
対して強い活性をもつ抗真菌性抗生物質を生産する能力
を有するという知見に基すいている。As an antifungal antibiotic, for example, amphotericin B1
Medicines such as griseofulvin and virolnidoline, and agricultural chemicals such as plasticidin S, polyoxin, validamycin, tetranactin, and bialafoss are known. However, the known antifungal antibiotics still have room for improvement in terms of efficacy, toxicity, antibacterial properties, etc.
This invention is based on the knowledge that the actinomycetes that the inventors isolated from soil have the ability to produce antifungal antibiotics that have particularly strong activity against plant pathogens.
が ゛しようとする 題
本発明の目的は、新規抗生物質OM−5714およびそ
の製法を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a novel antibiotic OM-5714 and a method for producing the same.
゛ るための
本発明により、次式(1)で表わされる抗生物質OM−
5714が提供される。According to the present invention, the antibiotic OM-
5714 is provided.
本抗生物質の理化学的性質は次の通りである。The physicochemical properties of this antibiotic are as follows.
■ 融点:58〜62℃ ■ 元素分析:実測値(%) C66,2±1.0 8 7.6±0.3 N 9.7±0.3 ■ 分子l:290.16 ■ 分子式: C、sHzzN t Os8 ■ 比旋光度: [α] +23.O。■ Melting point: 58-62℃ ■ Elemental analysis: Actual value (%) C66,2±1.0 8 7.6±0.3 N 9.7±0.3 ■ Molecule l: 290.16 ■ Molecular formula: C, sHzNt Os8 ■ Specific rotation: [α] +23. O.
(c=1.o、クロロホルム)
■ 紫外線吸収スペクトル(メタノール中):第1図の
通り
■ 赤外線吸収スペクトル(KBr法):第2図の通り
■ プロトン核磁気共鳴スペクトル(CDCI。(c=1.o, chloroform) ■ Ultraviolet absorption spectrum (in methanol): As shown in Figure 1 ■ Infrared absorption spectrum (KBr method): As shown in Figure 2 ■ Proton nuclear magnetic resonance spectrum (CDCI).
中): 第3図の通り
■ C−13核磁気共鳴スペクトル(CDC1S中):
第4図の通り
■ 溶剤に対する溶解性
可溶:メタノール、エタノール、酢酸エチル、クロロホ
ルム
不溶:水、n−ヘキサン
■ 呈色反応
陽性: H,SO,、ヨウ素、リン−モリブデン酸試薬
陰性:ニンヒドリン、エルソンーモルガン試薬
■ 酸性、中性、塩基性の別:中性物質@ 物質の色:
白色ないし淡黄色
次に本抗生物質の生物学的性質を示す。(middle): As shown in Figure 3 ■ C-13 nuclear magnetic resonance spectrum (in CDC1S):
As shown in Figure 4 ■ Solubility in solvents Soluble: methanol, ethanol, ethyl acetate, chloroform Insoluble: water, n-hexane ■ Positive color reaction: H, SO, iodine, phosphorus-molybdate reagent Negative: ninhydrin, Elson-Morgan reagent ■ Acidic, neutral, basic: Neutral substance @ Color of substance:
White to pale yellow Next, the biological properties of this antibiotic are shown.
■)抗菌活性
寒天希釈法による本抗生物質の最小発育阻止濃度CM
I C5単位μg/mlは第1表に示す通りである。■) Minimum inhibitory concentration CM of this antibiotic by antibacterial activity agar dilution method
The IC5 unit μg/ml is as shown in Table 1.
第 1 表
KB176 (NIHJ、 JC−2,IFO1273
4)番シュードモナス・エルギノーザ 〉100
(Ploo(Pseudo 7) P−3KB105参
キサントモナス・オリザエ 〉100(X1
00(Xantho カニ4些) KB88 IIミ
クロコツカス・ルテウス 〉100(Mic
rocoloo(1uteus) KB40 (PCI
!001)*スタフィロコッカス・アウレウス
〉100(Sta h 1ococcus aureu
s) KB34(FDA 209P)ネ
ミコバクテリウム・スメグマチス 〉1100f
cobacterium リ咀jμ見目) KB42
(ATCC607) *
バチルス・スブチリス 〉100(Ba
cillus 5ubtilisl KB27 (PC
I 219) *カンジダ・アルビカンス
〉100(Candida albicans) K
FI **サツカロミセス・サケ 〉1
100(Saccharo ces 5ake) KF
26参番アスペルギルス・ニガー 〉10
0(酊且虹工以上Is 11狂) KF103iAT
cc 6275) *参
ビリキュラリア・オリザエ 〉100(Pi
ricularia 虹■並)にF180會傘ムコール
・ラセモスス 〉100(Mloo(r
acea+osus) KF223+IF0 4581
1 傘幸
フィトフトーラ・カフトラム 12.5(P
h to hthora cactoruml
KF279 *参フィトフトーラ・バラシチカ
50[Ph to hthora 匹」社巨
匹IKF265 1F04783 *参
感受性寒天培地(日本製)37℃、
pH7,0,24時間目に判定。Table 1 KB176 (NIHJ, JC-2, IFO1273
4) Pseudomonas aeruginosa 〉100
(Ploo (Pseudo 7) P-3KB105 Reference Xanthomonas oryzae 〉100 (X1
00 (Xantho crab 4 small) KB88 II Micrococcus luteus 〉100 (Mic
rocoloo(1uteus) KB40 (PCI
! 001) * Staphylococcus aureus
〉100(Sta h 1ococcus aureu
s) KB34 (FDA 209P) Nemicobacterium smegmatis 〉1100f
cobacterium KB42
(ATCC607) * Bacillus subtilis >100 (Ba
cillus 5ubtilisl KB27 (PC
I 219) *Candida albicans
〉100(Candida albicans) K
FI ** Satsukaromyces salmon 〉1
100 (Saccharoces 5ake) KF
No. 26 Aspergillus niger 〉10
0 (Drunken and above Is 11 crazy) KF103iAT
cc 6275) *Villicularia oryzae 〉100(Pi
ricularia rainbow■ average) and F180 Mucor racemosus 〉100 (Mloo(r
acea+osus) KF223+IF0 4581
1 Kasayuki Phytophthora captrum 12.5 (P
h to hthora cactoruml
KF279 *Phytophthora balashtica
50 [Ph to hthora animals] IKF265 1F04783 * Ginseng sensitive agar medium (made in Japan) 37°C, pH 7, 0, determined at 24 hours.
一参 ポテトグルコース寒天培地 27℃、H6,01
3日 に 定。Issan Potato Glucose Agar Medium 27℃, H6.01
Set on the 3rd.
注: 参
前記の通り、本抗生物質は、例えばフィトフトーラ(P
h to hthora)属の真菌に生育阻害活性を示
す。Note: As mentioned above, this antibiotic can be used for example in Phytophthora (P
It exhibits growth inhibitory activity against fungi of the genus H to hthora.
2)除草活性
抗生物質OM−5714はloOppmの濃度で置割大
根の種子の発芽を20%以上阻害し、若芽の伸長を90
%以上阻害する。なお、除草活性の試験は次の方法によ
り行なった。小型試験管2本に各々脱脂綿を入れ、lO
OμgのOM−5714を含む水1 rsQで脱脂綿を
浸し、この上に置割大根の種子を5個ずつ播いた。試験
管の口を金属性の蓋で覆い、27℃で4日間蛍光灯の照
射下に置き、種子の発芽数及び背丈を測定した。2) Herbicidal activity The antibiotic OM-5714 inhibited the germination of radish seeds by 20% or more at a concentration of loOppm, and the elongation of young shoots was inhibited by 90%.
% or more. The herbicidal activity test was conducted using the following method. Put absorbent cotton into two small test tubes and add lO
Absorbent cotton was soaked in 1 rsQ of water containing 0 μg of OM-5714, and five seeds of Okiwari radish were sown thereon. The mouth of the test tube was covered with a metal lid and placed under fluorescent light irradiation at 27° C. for 4 days, and the number and height of seeds germinated were measured.
薬剤無添加の対象と比較して効果を判定した。The effect was determined by comparing with a control without any drug addition.
3)毒性
マウスに投与した場合の本抗生物質の急性毒性(L D
ao)は、30 mg/kg (腹腔内)以上、ま
たは100 B/kg (経口)以上であった。3) Acute toxicity of this antibiotic when administered to toxic mice (L D
ao) was greater than or equal to 30 mg/kg (intraperitoneal) or greater than or equal to 100 B/kg (oral).
次に本発明により、ストレプトミセス属に属しかつ抗生
物質OM−5714産生能力を有する微生物を培地に好
気的に培養し、培養物中に抗生物質OM−5714を蓄
積し、培養物からこれを採取する工程からなる、抗生物
質OM−5714の製法が提供される。Next, according to the present invention, a microorganism belonging to the genus Streptomyces and having the ability to produce the antibiotic OM-5714 is aerobically cultured in a medium, the antibiotic OM-5714 is accumulated in the culture, and the antibiotic OM-5714 is removed from the culture. A method for producing antibiotic OM-5714 is provided, comprising the step of harvesting.
本発明の抗生物質OM−5714を生産するために使用
される菌株としては、1例として、本発明者らによって
広島県福山市の土壌から新たに分離された、ストレプト
ミセス・エスピー・OM−5714株が挙げられる。As an example of the strain used to produce the antibiotic OM-5714 of the present invention, Streptomyces sp. OM-5714, which was newly isolated by the present inventors from the soil of Fukuyama City, Hiroshima Prefecture, Stocks are one example.
本菌株の菌学的性状は次のとおりである。The mycological properties of this strain are as follows.
+11形態的性質
栄養菌糸は各種寒天培地上でよく発達し、分断は観察さ
れない、気菌糸はグルコース・硝酸塩寒天以外で豊富に
着生し、白色あるいは灰色を呈する。顕微鏡下の観察で
は、気菌糸はらせん状を呈し、20個以上の胞子の連鎖
が認められる。胞子の大きさは1.07X0.75μI
である。胞子の表面は平滑あるいはしわ状である。菌核
、胞子のうおよび遊走子は見出されない。+11 Morphological properties Vegetative hyphae develop well on various agar media, and no division is observed.Aerial hyphae are abundantly attached to substrates other than glucose/nitrate agar and are white or gray in color. When observed under a microscope, the aerial mycelia have a spiral shape, and chains of 20 or more spores are observed. Spore size is 1.07X0.75μI
It is. The surface of the spore is smooth or wrinkled. No sclerotia, sporangia and zoospores are found.
(II) 各種培地上での性状
イー・ビー・シャーリング(E、 B、 Shirli
nglとデー・ゴツトリーブ(D、 Gottlieb
lの方法(インターナショナル・ジャーナル・オブ・シ
スティマチイック・バクテリオロタ−。16巻、313
頁、1966年)によって調べた本生産菌の培養性状を
法衣に示す0色調は標準色として、カラー・ハーモニー
・マニュアル第4版(コンテナー・コーポレーション・
オブ・アメリカ・シカゴ、1958年)を用いて決定し
、色票名とともに括弧内にそのコードを併せて記した。(II) Properties on various media E. B. Shirli
ngl and Gottlieb (D. Gottlieb)
Method of I (International Journal of Systematic Bacteriology. Vol. 16, 313)
The color tone 0 shown on the robe is the standard color, and the culture properties of this production bacterium were investigated by the Color Harmony Manual, 4th edition (Container Corporation, 1966).
of America, Chicago, 1958), and the code is written in parentheses along with the color chart name.
以下は特記しない限り、27℃、2週間目の各培地にお
ける観察の結果である。The following are the results of observations in each medium at 27°C for 2 weeks unless otherwise specified.
(III)生理学的諸性質
(1)メラニン色素の生成
(イ)チロシン寒天 陰性(11)ペ
プトン・イースト鉄寒天 陰性(ハ)グルコース・
ペプトン・
ゼラチン培地(21〜23℃) 陰性
(ニ)トリプトン・イースト液 陰性(2)チロ
シナーゼ反応 陰性(3)硫化水素の生
産 陰性(4)硝酸塩の還元
陽性(5)ゼラチンの液化(21〜23℃
)(グルコース・ペプトン・
ゼラチン培地) 陰性
(6) スターチの加水分解 陽性(7)
脱脂乳の凝固(37℃) 陰性(8)脱脂乳の
ペプトン化(37℃) @性(9)生育温度範囲
15℃〜38℃生育至適温度 29
℃
(!0)炭素源の利用法
(ブリーダム・ゴトリーブ寒天培地)
利用する:シュークロース以外は利用する(11)セル
ロースの分解 陰性(IVI 細胞壁
組成
細胞壁のジアミノピメリン酸はLL型である。(III) Physiological properties (1) Production of melanin pigment (a) Tyrosine agar negative (11) Peptone/yeast iron agar negative (c) Glucose/
Peptone-gelatin medium (21-23℃) Negative (d) Tryptone yeast solution Negative (2) Tyrosinase reaction Negative (3) Production of hydrogen sulfide Negative (4) Reduction of nitrate
Positive (5) Liquefaction of gelatin (21-23℃
) (glucose/peptone/gelatin medium) Negative (6) Starch hydrolysis Positive (7)
Coagulation of skim milk (37℃) Negative (8) Peptonization of skim milk (37℃) @Sensitive (9) Growth temperature range
Optimum temperature for growth 15℃~38℃ 29
℃ (!0) How to use carbon sources (Bleedam-Gotlieb agar medium) Use: Use everything except sucrose (11) Decomposition of cellulose Negative (IVI) Cell wall composition Diaminopimelic acid in the cell wall is LL type.
以上、植菌の菌学的性状を要約すると次のとおりである
。細胞壁中のジアミノピメリン酸はLL型である。気菌
糸の形態はらせん状で、長い胞子鎖を形成する。胞子の
表面は平滑である。培養状の諸性質としては、栄養菌糸
はブラウンあるいはオレンジの色調を呈し、気菌糸はホ
ワイトあるいはグレイの色調を呈する。可溶性色素は産
生しない。The mycological properties of the inoculation can be summarized as follows. Diaminopimelic acid in the cell wall is of the LL type. The aerial mycelium has a spiral shape and forms long spore chains. The surface of the spore is smooth. Regarding the properties of the culture, vegetative hyphae exhibit a brown or orange tone, and aerial hyphae exhibit a white or gray tone. No soluble pigments are produced.
これらの結果から、本菌株はストレプトミセス属に属す
る菌種であり、ブリドへムとトレスナーの分類(バーシ
ス・マニュアル・オブ・デターミネーティブ・バクテリ
オワジー。第8版、748〜829頁、1974年)に
よるグレイシリーズに属する菌種であると考えられる。From these results, this bacterial strain belongs to the genus Streptomyces, and is classified according to Bridhem and Tresner's classification (Versis Manual of Determinative Bacteriosis, 8th edition, pp. 748-829, 1974). ), it is considered to be a species belonging to the Gray series.
なお、本菌株はストレプトミセス・エスピー・(Str
e jam ces sp、] OM −5714と
して、工業技術院微生物工業技術研究所に寄託されてい
る(微工研菌寄第10775号)。This strain is Streptomyces sp.
e jam ces sp, ] OM-5714 and has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology (Fiber Science and Technology Research Institute No. 10775).
本発明による抗生物質OM−5714生産菌を培養する
ための培地としては、ストレプトミセス属の微生物の培
養に適する炭素源、窒素源、無機物、必要に応じてその
他の栄養物を程よく含有する合成培地または天然培地を
使用することができる。The medium for culturing the antibiotic OM-5714-producing microorganism according to the present invention is a synthetic medium suitable for culturing Streptomyces microorganisms, containing carbon sources, nitrogen sources, inorganic substances, and other nutrients in appropriate amounts as necessary. Or natural media can be used.
培地に使用される炭素源、窒素源は、使用菌株の利用可
能なものならばいずれの種類でもよい。The carbon source and nitrogen source used in the culture medium may be any type as long as they are available to the strain used.
例えば、炭素源としてはグルコース、グリセロール、フ
ラクトース、マルトース、マンニット、キシロース、ガ
ラクトース、リボース、澱粉またはその加水分解物等の
種々の炭水化物が使用できる。その濃度は通常、培地に
対して0.2%〜5%(グルコース換算)が好ましい、
また、グルコン酸、ピルビン酸、乳酸、酢酸等の各種有
機酸、グリシン、グルタミン酸、アラニン等の各種アミ
ノ酸、さらにはメタノール、エタノール等のアルコール
類やノルマルパラフィン等の各種の非芳香族炭化水素、
あるいは植物性もしくは動物性の各種の油脂等も使用可
能である。For example, various carbohydrates such as glucose, glycerol, fructose, maltose, mannitol, xylose, galactose, ribose, starch or its hydrolyzate can be used as the carbon source. Its concentration is usually preferably 0.2% to 5% (in terms of glucose) based on the medium.
In addition, various organic acids such as gluconic acid, pyruvic acid, lactic acid, and acetic acid, various amino acids such as glycine, glutamic acid, and alanine, alcohols such as methanol and ethanol, and various non-aromatic hydrocarbons such as normal paraffin,
Alternatively, various vegetable or animal fats and oils can also be used.
窒素源としては、アンモニア、塩化アンモニウム、燐酸
アンモニウム、硫酸アンモニウム、硝酸アンモニウム等
の各種の無機酸あるいは有機酸のアンモニウム塩類、尿
素、ペプトン、NZ−アミン、肉エキス、酵母エキス、
乾燥酵母、コーンスチープリカー、カゼイン加水分解物
、フィツシュミールあるいはその消化物、大豆粉あるい
はその消化物、脱脂大豆あるいはその消化物、輛加水分
解物等の含窒素有機物、さらにはグリシン、グルタミン
酸、アラニン等の各種アミノ酸が使用可能である。Nitrogen sources include ammonium salts of various inorganic or organic acids such as ammonia, ammonium chloride, ammonium phosphate, ammonium sulfate, ammonium nitrate, urea, peptone, NZ-amine, meat extract, yeast extract,
Nitrogen-containing organic substances such as dry yeast, corn steep liquor, casein hydrolyzate, fitschmeal or its digested product, soybean flour or its digested product, defatted soybean or its digested product, soybean hydrolyzate, as well as glycine, glutamic acid, Various amino acids such as alanine can be used.
無機物としては各種燐酸塩、硫酸マグネシウム、食塩等
、さらに微量の重金属塩が使用される。As inorganic substances, various phosphates, magnesium sulfate, common salt, etc., and trace amounts of heavy metal salts are used.
栄養要求性を示す変異株を用いる場合には、当然その栄
養要求を満足させる物質を培地に加えなければならない
が、この種の栄養素は、天然物を含む培地を使用する場
合には特に添加を必要としない場合がある。When using a mutant strain that exhibits auxotrophy, it is naturally necessary to add substances that satisfy its nutritional needs to the culture medium, but this kind of nutrients should especially not be added when using a medium containing natural products. It may not be necessary.
発酵は振盪培養または通気撹拌深部培養等の好気条件下
で行なう、培養温度は通常20℃〜40℃で、pHは4
〜9(特に7付近)である、培養期間は通常1〜7日で
菌体内外に抗生物質OM−5714が生成蓄積する。Fermentation is carried out under aerobic conditions such as shaking culture or aeration-stirring submerged culture. The culture temperature is usually 20°C to 40°C, and the pH is 4.
-9 (particularly around 7), and the culture period is usually 1 to 7 days, and the antibiotic OM-5714 is produced and accumulated inside and outside the bacterial cells.
培養終了後に培養物より抗生物質OM −5714を例
えば次の方法で揉取する。After completion of the culture, the antibiotic OM-5714 is collected from the culture by, for example, the following method.
培養物を遠心分離により濾液と沈殿物とに分離する。濾
液から多孔性高分子樹脂に吸着させ、溶出さることによ
り抽出する。抽出物を適宜濃縮乾固することにより抗生
物質OM−5714の粗物質を得る。粗物質はさらに、
脂溶性物質の精製に通常用いられる公知の方法、例えば
シリカゲル等の吸着剤、ゲル濾過剤などを用いる各種ク
ロマトグラフィー法、濃縮法、塩析法等を単独または適
宜組み合わせることにより精製する。抗生物質OM−5
714の精製に好適な例として、逆層型充填剤を用い、
溶出溶液としてアセトニトリルと水との混液を用いる濃
度勾配溶出法による高速液体クロマトグラフィー法があ
げられる。これらの方法で得られる活性画分を濃縮乾固
することにより抗生物質OM−5714の精製粉末を得
ることができる。The culture is separated into a filtrate and a precipitate by centrifugation. It is extracted from the filtrate by adsorbing it onto a porous polymer resin and eluting it. The crude substance of antibiotic OM-5714 is obtained by appropriately concentrating the extract to dryness. The crude substance is further
Purification is carried out by known methods commonly used for the purification of fat-soluble substances, such as various chromatography methods using adsorbents such as silica gel, gel filtration agents, concentration methods, salting-out methods, etc. alone or in appropriate combinations. Antibiotic OM-5
As a suitable example for purifying 714, using a reverse bed type packing material,
Examples include high performance liquid chromatography using a concentration gradient elution method using a mixture of acetonitrile and water as an elution solution. A purified powder of antibiotic OM-5714 can be obtained by concentrating and drying the active fraction obtained by these methods.
本明細書において、抗生物質OM−5714の検出及び
定置は、シリカゲル薄層クロマトグラフィー(メルク社
製、シリカゲル、薄層板No。In this specification, the detection and emplacement of the antibiotic OM-5714 was carried out using silica gel thin layer chromatography (manufactured by Merck & Co., Ltd., silica gel, thin layer plate No.
5554、厚さ0.2mn+、展開溶媒:クロロホルム
/メタノール=9:l、本抗生物質のRf(直0.3付
近)及びフィトフトーラ・バラシチカ・バール・ニコチ
アナエ (Ph to hthora眩匡旦旦」var
、 n1cotianael K F −265を用
いる生物学的検定法によった。5554, thickness 0.2 mm+, developing solvent: chloroform/methanol = 9:l, Rf of this antibiotic (nearly 0.3) and Phytophthora var. var.
, by a bioassay using n1cotianael K F-265.
以下に実施例を示す。Examples are shown below.
X嵐五ユ
ストレプトミセス・エスピー(Stre ton ce
ssp、)OM−5714株(微工研菌寄第10775
号)の斜面培養から1白金耳を100mfiの種培地(
@扮2.4%、グルコースO,1%、ペプトン03%、
肉エキス0.3%、酵母エキス0.5%、CaCO50
、4%、pH7,0)を入れた500 IIIQ容の坂
ロフラスコに接種し、27℃で2日間振盪培養して種培
養液を得た。X Arashigo Streptomyces sp.
ssp,) OM-5714 strain (Feikoken Bacterial Serial No. 10775
Transfer one platinum loop from the slant culture of 100 mfi seed medium (
@2.4% Glucose O, 1%, Peptone 03%,
Meat extract 0.3%, yeast extract 0.5%, CaCO50
, 4%, pH 7.0) in a 500 IIIQ capacity Sakaro flask, and cultured with shaking at 27°C for 2 days to obtain a seed culture.
こうして得られた種培養液4gを、抗生物質生産用培地
2002を入れた4002のファーメンタ−に移植し、
27℃で3日間通気撹拌培養(通気量:lOQ/分、撹
拌:200rpm)を行なった0発泡を押えるためにア
デカノールLG−109(旭電化社製)を適宜添加した
。抗生物質OM−5714生産用培地として次の組成の
培地を用いた。4 g of the seed culture solution obtained in this way was transplanted into a 4002 fermenter containing antibiotic production medium 2002,
Aeration and agitation culture (aeration rate: 1OQ/min, agitation: 200 rpm) was carried out at 27° C. for 3 days. Adekanol LG-109 (manufactured by Asahi Denka Co., Ltd.) was appropriately added to suppress zero foaming. A medium having the following composition was used as a medium for producing antibiotic OM-5714.
可溶性澱粉 2 %
グリセロール 0.5%
小麦胚芽 1.0%
肉エキス 0.3%
乾燥酵母 0.3%
CaCO50,3%
pH7,5
培養液1959に等量の酢酸エチルを加えて活性物質を
抽出し、酢酸エチル層を濃縮乾固して油状物質140g
を得た。油状物質を12のクロロホルムに溶解し、不溶
物を除去した。クロロホルムに懸濁したシリカゲル(約
1 kg)を充填したカラム(約22.6c層x 75
cm)の上端に、上記の油状物質を少量のシリカゲル
とともに負荷し、クロロホルム/メタノール(50:
1. v/v ) (3℃)、クロロホルム/メタノ
ール(20:l。Soluble starch 2% Glycerol 0.5% Wheat germ 1.0% Meat extract 0.3% Dried yeast 0.3% CaCO50.3% pH 7.5 Add an equal volume of ethyl acetate to culture solution 1959 to extract active substances Then, the ethyl acetate layer was concentrated to dryness to obtain 140 g of oily substance.
I got it. The oily substance was dissolved in 12 chloroform and insoluble materials were removed. A column packed with silica gel (approximately 1 kg) suspended in chloroform (approximately 22.6 c layers x 75
cm), the above oil was loaded with a small amount of silica gel and chloroform/methanol (50:
1. v/v) (3°C), chloroform/methanol (20:l.
v/v)(21!、)で溶出した0分画容量は約201
氾とした。活性画分(No、136〜190)を集め、
減圧下でaIli!することにより、淡褐色の粗粉末2
.1gを得た。この粗粉末(2,0g)を常法により少
量のシリカゲルに吸着させた。これを、ベンゼンにjl
J ffiしたシリカゲルを充填したカラム(200m
Il、1 、 l cmX 60 am)の上端に負
荷し、
ベンゼン/アセトン 50:l(v/v)//
5:l(v/v)n 2
:1(v/vlの順に溶出溶媒を順次変えながら、各々
約150〜200mnずつ溶出した6分画容量は約20
1βであった。活性画分(No、15〜26)を集め、
減圧下で濃縮することにより、抗生物質OM−5714
の黄色粉末410mgを得た。The volume of the 0 fraction eluted with v/v) (21!,) is approximately 201
It was a flood. Collect active fractions (No. 136-190),
aIli under reduced pressure! By doing this, light brown coarse powder 2
.. 1g was obtained. This coarse powder (2.0 g) was adsorbed onto a small amount of silica gel by a conventional method. Add this to benzene
Column packed with silica gel (200 m
benzene/acetone 50:l (v/v) //
5:l(v/v)n2
:1 (while changing the elution solvent sequentially in the order of v/vl, the volume of the 6 fractions eluted at about 150 to 200 mm each was about 20
It was 1β. Collect active fractions (No. 15-26),
Antibiotic OM-5714 by concentration under reduced pressure
410 mg of yellow powder was obtained.
本試料100mgを少量のアセトニトリルに溶解し、高
速液体クロマトグラフィーでさらに精製した。カラム担
体としてオーデイ−ニス(ODS)−18(山村科学社
製YMC0DS−5)(カラムサイズ20X250mm
)を用い、溶媒は30%アセトニトリル水を用いた。流
速は8ml/分とした。275nmでの紫外線吸収で活
性物質を検出し、保持時間22.5分付近に溶出される
物質を集めた。この画分な濃縮乾固し、抗生物質OM−
5714の淡黄色精製粉末を17.5B得た。100 mg of this sample was dissolved in a small amount of acetonitrile and further purified by high performance liquid chromatography. Odynis (ODS)-18 (YMC0DS-5 manufactured by Yamamura Scientific Co., Ltd.) (column size 20 x 250 mm) was used as a column carrier.
), and 30% acetonitrile water was used as the solvent. The flow rate was 8 ml/min. Active substances were detected by ultraviolet absorption at 275 nm, and substances eluted around a retention time of 22.5 minutes were collected. This fraction was concentrated to dryness and the antibiotic OM-
17.5B of pale yellow purified powder of 5714 was obtained.
本試料はシリカゲル薄層クロマトグラフィーにおいてク
ロロホルム/メタノール(9: 1.v/v)。This sample was analyzed using silica gel thin layer chromatography using chloroform/methanol (9:1.v/v).
ベンゼン/アセトン(3: 1. v/v )で展開し
た場合、単一スポットを与えた。また逆相型カラムを用
いる高速液体クロマトグラフィーで単一ピークを与えた
。When developed with benzene/acetone (3:1. v/v) a single spot was given. A single peak was also obtained by high-performance liquid chromatography using a reversed-phase column.
本精製粉末の理化学的性質は、前記のとおりであった。The physicochemical properties of this purified powder were as described above.
足置jと仇釆
抗生物質OM−5714は、主として植物病原性真菌に
活性を示し、また除草活性も有するので、例えば農薬と
して有用であることが期待される。The antibiotic OM-5714 is mainly active against plant pathogenic fungi and also has herbicidal activity, so it is expected to be useful, for example, as a pesticide.
第1図は抗生物質OM−5714の紫外線吸収スペクト
ル(メタノール中)、第2図は赤外線吸収スペクトル(
KBr法)、第3図はプロトン核磁気共鳴スペクトル(
CDC1,中)、’JI4図はC−13核磁気共鳴スペ
クトル(CDels中)を示す。Figure 1 shows the ultraviolet absorption spectrum (in methanol) of the antibiotic OM-5714, and Figure 2 shows the infrared absorption spectrum (in methanol).
KBr method), Figure 3 shows the proton nuclear magnetic resonance spectrum (
CDC1, in), 'JI4 figure shows C-13 nuclear magnetic resonance spectrum (in CDels).
Claims (2)
]比旋光度:▲数式、化学式、表等があります▼ (c=1.0、クロロホルム) [6]紫外線吸収スペクトル(メタノール中):第1図
の通り [7]赤外線吸収スペクトル(KBr法):第2図の通
り [8]プロトン核磁気共鳴スペクトル(CDCI_3中
): 第3図の通り [9]C−13核磁気共鳴スペクトル(CDCI_3中
): 第4図の通り [10]溶剤に対する溶解性 可溶:メタノール、エタノール、酢酸 エチル、クロロホルム 不溶:水、n−ヘキサン [11]呈色反応 陽性:H_2SO_4、ヨウ素、リン−モリブデン酸試
薬 陰性:ニンヒドリン、エルソン−モル ガン試薬 [12]酸性、中性、塩基性の別:中性物質[13]物
質の色:白色ないし淡黄色(1) Antibiotic OM-5714 represented by formula (I). ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [1] Melting point: 58-62℃ [2] Elemental analysis: Actual value (%) C 66.2±1.0 H 7.6±0.3 N 9.7 ±0.3 [3] Molecular weight: 290.16 [4] Molecular formula: C_1_6H_2_2N_2O_3 [5
]Specific rotation: ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (c=1.0, chloroform) [6] Ultraviolet absorption spectrum (in methanol): As shown in Figure 1 [7] Infrared absorption spectrum (KBr method) : As shown in Figure 2 [8] Proton nuclear magnetic resonance spectrum (in CDCI_3): As shown in Figure 3 [9] C-13 nuclear magnetic resonance spectrum (in CDCI_3): As shown in Figure 4 [10] Dissolution in solvent Soluble: methanol, ethanol, ethyl acetate, chloroform Insoluble: water, n-hexane [11] Color reaction positive: H_2SO_4, iodine, phosphorus-molybdic acid reagent Negative: ninhydrin, Elson-Morgan reagent [12] Acidic, medium Nature and basicity: Neutral substance [13] Color of substance: White to pale yellow
項記載の抗生物質OM−5714を生産する能力を有す
る菌株を培地に培養し、培養物中に抗生物質OM−57
14を生成蓄積させ、該培養物からOM−5714を採
取することを特徴とする抗生物質OM−5714の製造
法。(2) Belongs to the genus Streptomyces, and the first claim
A strain having the ability to produce the antibiotic OM-5714 described in Section 1 is cultured in a medium, and the antibiotic OM-57 is added to the culture.
A method for producing antibiotic OM-5714, which comprises producing and accumulating OM-14 and collecting OM-5714 from the culture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14509989A JPH0310692A (en) | 1989-06-09 | 1989-06-09 | Antibiotic substance om-5714 and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14509989A JPH0310692A (en) | 1989-06-09 | 1989-06-09 | Antibiotic substance om-5714 and production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0310692A true JPH0310692A (en) | 1991-01-18 |
Family
ID=15377354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14509989A Pending JPH0310692A (en) | 1989-06-09 | 1989-06-09 | Antibiotic substance om-5714 and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0310692A (en) |
-
1989
- 1989-06-09 JP JP14509989A patent/JPH0310692A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6016236B2 (en) | Production method of antibiotic C-15003 P-3 | |
US4764602A (en) | Antibiotics, and their production | |
JPH0310692A (en) | Antibiotic substance om-5714 and production thereof | |
US4940582A (en) | Antibiotic YI-HU3 | |
US5516686A (en) | Fungicidal antibiotic producing Streptomyces sp. NCIMB 40212 | |
JPH0353891A (en) | New antibiotic substance sf2197c and production thereof | |
JPH01228484A (en) | Antibiotic substance wk-1875 and production thereof | |
JPS62294676A (en) | Patulolide and production thereof | |
JPH06234784A (en) | New antibiotic sf 2768 substance and its production | |
JPS6034556B2 (en) | Antibiotic C-15003 | |
KR820001204B1 (en) | Method for producing antibiotic c-15003 p-3 | |
JP2990628B2 (en) | New plant growth regulating substance aji-302 and its production | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH01199582A (en) | Novel antibiotic fo-125a4, a5 or b and production thereof | |
JPH0429995A (en) | New antibiotic substance wf3010 and its production | |
JPH0366307B2 (en) | ||
JPS5834112B2 (en) | New antibiotic SF-1540-B substance and its production method, and agricultural antifungal agent | |
JPH0737478B2 (en) | Novel bioactive substance KSA-9342 or salt thereof, and method for producing the same | |
JPS61189280A (en) | Novel physiologically active substance ss43405e and production thereof | |
JPH02312586A (en) | New physiologically active substance sn-198c-forming bacterium, new physiologically active substance sn-198c and its production | |
JPS62228074A (en) | Substance ss50408 and production thereof | |
JPS62149693A (en) | Antibiotic substance ss42227b and production thereof | |
JPS5932120B2 (en) | Method for producing 9-β-D arabinofuranosyl adenine | |
JPS58121794A (en) | Antibiotic tt-52992, its preparation and microorganism | |
JPH0680607A (en) | Malbranicin |